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Antibiotics, How Do They Act? 
By 
Jerry P. Kunesh, D.V.M., M.S., Ph.D.* 
Most people agree that for a thorough 
understanding of any subject the mecha-
nism of action must be known. 
In thc area of the biological sciences, 
particularly pathology, pharmacology, and 
medicine, the exact mechanism of action 
of the disease produCing agent or of the 
drug which is used to cure the disease is 
not known. It can generally be said that 
we have a cause and effect understanding 
in this area, but we do not understand the 
actual biochemical changes which are 
being produced by either the disease pro-
ducing agent or the drug or drugs which 
reverse the disease process. 
We can go further and say that the exact 
mechanism of action of many materials 
which are essential for normal physiologi-
cal function of the body are not known. 
For the above reasons these areas are gen-
erally taught as "classical" su'~jects and 
the presentation is essentially that of stat-
ing facts which have been gained from ob-
servation without a true explanation of the 
real mechanism of action. 
Inroads are now being made into lhis 
area through le~earch at the bicchemical 
level and eventually a complete under-
standing of the mechanism of action of 
essential metabolites, disease pro:luction, 
and drug action will be achieved. 
An idea of the type of work which must 
be done can be gained from study of tl:e 
mechanism of action of the antibiotics. 
Because a considerable amount of work 
has been done with the antibiotics, it is 
possible to classify them basically into four 
groups as to their site of action on the 
microbial agent which they affect. These 
sites of action are: 
1. On the bacterial cell wall 
2. On the cell membrane 
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3. Somewhere within the chain of events 
which is responsible for protein syn-
thesis 
4. Somewhere within the nucleic acid 
metabolism scheme 
To date, no antibiotics of therapeutic value 
have been found which interfere with in-
termediary metabolism. There may be 
very good reasons for this. If an antibiotic 
interfered with intermediary metabolism 
of the microbial agent, it would very pos-
Sibly also interfere with the intermediary 
metabolism of the host and, therefore, be 
too toxic for geneI31 therapeutic use. 
The only wayan antibiotic which affects 
intermediary metabolism could be used 
for d. erapeutic purposes would be if it af-
fected some intermediary metabolic pro-
cefS which is peculiar to the microbial 
agent. Such an agent has, in fact, been 
found though not among the antibiotics. 
The sulfonamides act through such a 
mechanism of action. It was found that 
t~ e sulfonamides act through competitive 
inhibition of para-amino-benzoic acid.! Ba-
sically, what happens is that due to the very 
close similarity in the structure of the ac-
tive part of any sulfonamide and para-
amino-benzoic acid, cacterial organisms 
will absorb the sulfonamide and "errone-
ously" substitute it for para-amino-benzoic 
acid. When this occurs, it prevents the re-
action between pteric acid and glutamic 
acid which is necesary to form pteroyl-
glutamic acid (another name for folic 
acid). 
Unfortunately, the exact function of 
para-amino-benzoic acid in this reaction 
is r.ot known. The sulfonamides do, how-
ever, block that vital role of para-amino-
benzoic acid and bacterial multiplication 
ceases. The bacteria are not killed; their 
rr:ultiplication has only been stopped and 
in this case the body defense mechanisms 
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must come into play to rid the body of 
disease. 
There are two reasons why bacterial 
organisms are resistant to sulfonamides. 
1. The microorganism produces its own 
para-amino-benzoic acid and does not 
depend on absorption of this metabolite 
from the media. It is not, therefore, 
affected by the sulfonamides. 
2. The microbial organism does not pro-
duce its own folic acid but absorbs 
this from the surrounding media' and, 
therefore, presents no place for the sul-
fonamide to act. 
The reason that the sulfonamides do not 
pose any great threat to the host cell is 
that the host requires folic acid in its diet 
and does not produce its own. As a result 
there is no intermediary metabolism sit~ 
at which the sulfonamide can act. This 
mechanism of action also explains why 
cross reistance is not seen between sul-
fonamides and antibiotics to which a 
microbial agent would normally be sus-
ceptable. 
The antibiotics have generally been 
placed into various groups according to 
their site of action as follows: 
1. Those agents acting on the cell wall 
a. The penicillins 
b. The cephalosporins 
c. The bacitracins 
d. Cycloserine 
e. Vancomycin 
f. Ristocetin 
g. Novobiocin 
h. Oxamycin 
2. Those agents acting on the cell mem-
brane 
a. The polymyxins 
b. Colistin 
c. Novobiocin 
d. Tyrocidin 
e. Gramicidin 
f. Streptomycin 
g. Neomycin 
h. Kanamycin 
i. Nystatin 
j. Amphotericin 
3. Those agents affecting protein synthesis 
a. The tetracyclines 
b. The streptomycins 
c. Neomycin 
d. Erythromycin 
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e. Chloramphenicol 
f. Tylosin 
g. Lincomycin 
h. Oleandomycin 
i. Kanamycin 
4. Those affecting nucleic acid metabolism 
a. Actinomycin 
b. Griseofulvin 
It is very evident that some antibiotics 
act at more than one site or place in the 
bacterial agents vital metabolic processes. 
Another very outstanding defect in this 
breakdown of bacterial action is that it 
does not explain the exact mechanism of 
action which must be different for antibi-
otics within the same grouping since many 
times, cross resistance is not seen among 
antibiotics having the same general site 
of action. This implies that the specific 
site and the specific mechanism of action 
must be quite different. 
Presumably, the specific site and mecha-
nism of action of antibiotics which are 
closely related chemically is the same be-
cause as a general rule those antibiotics 
which are closely chemically related show 
complete cross resistance. The specific 
mechanism of action has been studied for 
very few antibiotics, however, and al-
though the general site of action is known 
the specific chemical site of action has no; 
generally been determined even for these. 
A brief, somewhat simplified discussion of 
those mechanisms of actions of antibiotics 
which are best understood follows. At this 
point in the practice of Veterinary Medi-
cine, the penicillins are the most impor-
tant of the group of antibiotics which act 
on the bacterial cell wall. This also is the 
antibiotic whose mechanism of action has 
been worked out in the greatest detail. 
Penicillin prevents formation of the 
cell wall of the bacterium by interfering 
with the formation of mucopeptides which 
are necessary in the cell wall.2•a.4 The 
penicillins are generally considered to be 
bacteriocidal, actually killing bacteria, 
rather than bacteriostatic which simply in-
hibits growth. The evidence indicates 
that penicillin interferes with cell wall 
growth to cause its bacteriocidal effect. 
Specifically, penicillin blocks the formation 
of a mucopeptide polymer which, in 
staphylococci, consists of N-acetylmuramic 
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acid, N-acetylglucosamine. glycine, D-glu-
tamic acid .. L-Iysine, D-alanine. and L-
alanine. In the Gram + bacteria. mu~o­
peptides form the most important and pos-
sibly only rigid supports of the cell. The 
rigid supports of the cell wall protect the 
underlying cell membrane from damage 
by the high internal osmotic pressure pres-
ent when bacteria are growing in a media 
of normal osmolarity. This high pressure 
results from the concentration of l;iolutes 
within the cell. The resulting damitge to 
the unprotected cell membrane leads .to 
death of the cell and many times even to 
lysis of the cell. What is actually happen-
ing to the bacterium is that the main mu-
co peptide chain of N-Ac-glucosamine and 
N-Ac-muramic acid continues to for~ but 
the linkages between the side changes are 
blocked.~ What happens then is that the 
peptides which would normally be utilized 
to form these cross links accumulate in 
the cell and, as a result, attract water in 
an attempt to equalize the osmotic pres-
sure. Since the cell wall is defective, it 
cannot give support and as the water goes 
into the cell, the cell membrane stretches 
until finally it bursts, and the bacterium is 
dead.'i.7.K There is evidence that penicillin 
can also kill dormant bacteria, but thhe 
mechanism for this has not yet been 
worked out. 
That Gram negative bacteria are less 
sensitive to penicillin is well known. Gram 
negative bacteria do undergo a swelling 
procedure when grown in the presence of 
penicillin, but they do not actually rupture. 
Penicillin acts only on the muramic acid 
containing mucopeptides which make up 
the main supporting structure of the gram 
positive bacteria. Gram negative bacteria 
also contain muramic acid mucopeptides 
but in addition have other supporting ma-
terials so that even if the mucopeptide 
support is lost they are still strong enough 
to resist rupture. It takes higher concen-
trations of penicillin to suppress gram 
negatives than gram positives but many 
can be <.;uppressed with it. 
On first ('xamination it would appear 
that penicillin would also be detrimental 
to ttll! animal cells. Penicillin, however. is 
very lIontoxic to animal cells because it 
acts rJIIly Oll muramic acid containing 
mucopeptides. and these are found only in 
bacterial cell walls. The cell membrane 
of an animal does not contain muramic 
acid. Toxicity which is usually associated 
with penicillin is due to the form of the 
penicillin rather than to penicillin itself. 
Of those agents which inferfere with 
protein synthesis, streptomycin has been 
studied to the greatest extent and lends it-
self to a fairly extensive discussion. 
Streptomycin attaches to the 30S sub-
unit of the ribosomes.Ii. 111 Exactly where or 
how it attaches is not known. Studies to 
date show that the streptomycin must at-
tach to the 30S subunit before the two 
subunits of the ribosome combine to form 
the entire ribosome. The site on the 308 
subunit is very specific, and those bacteria 
wl-ich do not have this site are resistant. ll . 
l:!.l:I.U This site presumably is also absent 
on the mammalian ribosome. In those bac-
teria which are susceptable after the strep-
tomycin attaches and the ribosome is 
formed, the ribosome starts to incorrectly 
incorporate the amino acid, phenylalanine, 
into proteins which are formed. ll ·ll'.i For 
example, pheylalanine may be substituted 
for isoleucine, leucine. serine, or some 
other amino acid which has a genetic code 
similar to phenylalanine. When this oc-
curs. proteins are still formed but the pro-
teins formed are nonfunctional and, as a 
result. all bacterial multiplication and ac-
tivity stops. 
Because of the way it acts. streptomycin 
is effective only in bacteria which are rap-
idly multiplying. and it has little or no ef-
fect on dormant bacteria. There is some 
evidence that streptomycin also affects the 
cell membrane. exerting a detergent-like 
effect, but its main activity is to interfere 
with protein synthesis. Another import-
ant consideration in the use of streptomy-
cin is that it generally does not kill, bac-
teria. Because of this, the body defense 
mechanisms must be functioning before 
satisfactory results are obtained. In ot'"er 
words. it is most effective in the acute 
stages of the infectious disease process. 
Another group of antibiotics which fall 
into this same group as far as mechanism 
of action is concerned are the tetracyclines. 
Thc most common are oxytetracycline, 
chlortetracycline. tetracycline. and de-
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methychlortetracycline. The exact mecha-
nism of action of these is not completely 
understood, but three theories have been 
advanced to explain their action. They are: 
1. They actively chelate cations. 
2. They inhibit essential enzyme systems. 
3. They suppress protein synthesis. 
There is a tendency to discount the first 
theory, that the effect is due to chelation 
of ions. It is true that the tetracyclines do 
chelate certain cations, but it appears 
highly unlikely that this is their main ac-
tion because extensive chelation of cations 
would produce deficiency symptoms in the 
animal, and this does not occur in tetra-
cycline therapy. 
This fact has a practical application in 
that absorption from the gastrointestinal 
tract is increased if these antibiotics are 
administered in the absence of calcium 
and magnesium. This needs to be especi-
ally taken into account when the tetracy-
clines are administered orally to animals 
on all milk diets. 
'The last two theories (inhibition of es-
sential enzyme systems and suppression 
of protein synthesis) may in fact be one 
and the same. Enzymes are proteins, and 
if an antibiotic suppresses protein forma-
tion, it will suppress enzyme formation 
and, thereby, interfere with enzyme sys-
tems. It has definitely been shown that 
the tetracyclines suppress protein forma-
tion but exactly how is not known. 11I At 
least it has not been studied to the degree 
that streptomycin has. 
Those antibiotics which have been de-
scribed as having a detergent-like effect on 
the cell membrane present a rather vague 
picture when one tries to explain how they 
could possess a detergent- like effect which 
is detrimental to the point of causing bac-
teriostatic or even bacteriocidal activity. 
It would appear that these agents would 
affect the host cells in the same manner. 
Yet, in practice this presumably does not 
occur. This indicates that the conditions 
of the cell membranes must differ from the 
host cell to the bacterial cell if this mecha-
nism and site of action is correct. 
An excellent review of the information 
available on the mechanism of action of 
antibiotics has been published.17 As of the 
date of that publication, the only antibiotic 
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whose activity could be completely ex-
plained from a biochemical standpoint was 
D-cycloserine. 
It seems logical to assume that if the 
exact chemical site of action and the exact 
chemical reaction at this site were known, 
it would be possible to administer chemi-
cal compounds to stop almost any disease 
process. Further, if we could administer 
such specific chemicals, it might be pos-
sible to avoid all of the toxic reactions 
which are now associated with antibiotic 
therapy. 
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